A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis
Authors
Keywords
-
Journal
NATURE
Volume 546, Issue 7658, Pages 376-380
Publisher
Springer Nature
Online
2017-05-31
DOI
10.1038/nature22337
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PI4 Kinase Is a Prophylactic but Not Radical Curative Target in Plasmodium vivax-Type Malaria Parasites
- (2016) Anne-Marie Zeeman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals
- (2016) Li Liu et al. LANCET
- Cryptosporidiosis Drug Discovery: Opportunities and Challenges
- (2016) Ujjini H. Manjunatha et al. ACS Infectious Diseases
- Correlation Between Diarrhea Severity and Oocyst Count via Quantitative PCR or Fluorescence Microscopy in Experimental Cryptosporidiosis in Calves
- (2015) Darwin J. Operario et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Gift from Nature: Cyclomarin A Kills Mycobacteria and Malaria Parasites by Distinct Modes of Action
- (2015) Nathalie Bürstner et al. CHEMBIOCHEM
- A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium
- (2015) William Checkley et al. LANCET INFECTIOUS DISEASES
- Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum
- (2015) Sumiti Vinayak et al. NATURE
- Direct inhibitors of InhA are active against Mycobacterium tuberculosis
- (2015) U. H. Manjunatha et al. Science Translational Medicine
- A Proposed Target Product Profile and Developmental Cascade for New Cryptosporidiosis Treatments
- (2015) Christopher D. Huston et al. PLoS Neglected Tropical Diseases
- Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)
- (2015) James A Platts-Mills et al. Lancet Global Health
- Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics
- (2014) Sonja Ghidelli-Disse et al. MALARIA JOURNAL
- Lead Optimization of Imidazopyrazines: A New Class of Antimalarial with Activity on Plasmodium Liver Stages
- (2014) Bin Zou et al. ACS Medicinal Chemistry Letters
- Drug Repurposing Screen Reveals FDA-Approved Inhibitors of Human HMG-CoA Reductase and Isoprenoid Synthesis That Block Cryptosporidium parvum Growth
- (2013) Kovi Bessoff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
- (2013) Karen L Kotloff et al. LANCET
- Parasitic infections: Time to tackle cryptosporidiosis
- (2013) Boris Striepen NATURE
- Targeting Plasmodium PI(4)K to eliminate malaria
- (2013) Case W. McNamara et al. NATURE
- Description of fecal shedding of Cryptosporidium parvum oocysts in experimentally challenged dairy calves
- (2013) Jennifer A. Zambriski et al. PARASITOLOGY RESEARCH
- Cryptosporidium parvum: Determination of ID50 and the dose–response relationship in experimentally challenged dairy calves
- (2013) J.A. Zambriski et al. VETERINARY PARASITOLOGY
- 3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential
- (2012) Yassir Younis et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Comparison of Fecal Percent Dry Matter and Number of Cryptosporidium parvum Oocysts Shed to Observational Fecal Consistency Scoring in Dairy Calves
- (2011) Mary L. Bellosa et al. JOURNAL OF PARASITOLOGY
- Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
- (2011) S. Meister et al. SCIENCE
- Spiroindolones, a Potent Compound Class for the Treatment of Malaria
- (2010) M. Rottmann et al. SCIENCE
- A Screening Pipeline for Antiparasitic Agents Targeting Cryptosporidium Inosine Monophosphate Dehydrogenase
- (2010) Lisa Sharling et al. PLoS Neglected Tropical Diseases
- Red-emitting luciferases for bioluminescence reporter and imaging applications
- (2009) Bruce R. Branchini et al. ANALYTICAL BIOCHEMISTRY
- High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial
- (2009) Beatrice Amadi et al. BMC INFECTIOUS DISEASES
- Molecular epidemiology of cryptosporidiosis: An update
- (2009) Lihua Xiao EXPERIMENTAL PARASITOLOGY
- Artificial Membrane Assays to Assess Permeability
- (2008) Bernard Faller CURRENT DRUG METABOLISM
- CryptosporidiumInfection of Human Intestinal Epithelial Cells Increases Expression of Osteoprotegerin: A Novel Mechanism for Evasion of Host Defenses
- (2008) Alejandro Castellanos‐Gonzalez et al. JOURNAL OF INFECTIOUS DISEASES
- Detection and differentiation of Cryptosporidium hominis and Cryptosporidium parvum by dual TaqMan assays
- (2008) N. Jothikumar et al. JOURNAL OF MEDICAL MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More